Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

NCT00777530 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Tumors
Leukemia

Interventions

DRUG: Bosutinib (SKI-606)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer